N-(1-isopentyl-3-pyrrolidyl)-N-(5-isoquinolyl)amine

ID: ALA375736

PubChem CID: 17838150

Max Phase: Preclinical

Molecular Formula: C19H27N3

Molecular Weight: 297.45

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)CCN1CCCC(Nc2cccc3cnccc23)C1

Standard InChI:  InChI=1S/C19H27N3/c1-15(2)9-12-22-11-4-6-17(14-22)21-19-7-3-5-16-13-20-10-8-18(16)19/h3,5,7-8,10,13,15,17,21H,4,6,9,11-12,14H2,1-2H3

Standard InChI Key:  XKFVECMYSQQWFL-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 22 24  0  0  0  0  0  0  0  0999 V2000
   -4.3693  -16.7565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6544  -17.1694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9380  -16.7560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9409  -15.9255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3681  -15.9291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6573  -15.5176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6593  -14.6981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3714  -14.2892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0829  -14.7058    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0774  -15.5239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2283  -15.5096    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5119  -15.9188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5106  -16.7424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7983  -17.1515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0834  -16.7391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0853  -15.9132    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8022  -15.4996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6286  -15.4997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3436  -15.9113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0576  -15.4979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7726  -15.9094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0565  -14.6729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  4 11  1  0
  5  1  2  0
 12 11  1  0
 12 13  1  0
  5  6  1  0
  2  3  2  0
  6  7  1  0
  7  8  2  0
 12 17  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
  3  4  1  0
 16 18  1  0
  8  9  1  0
 18 19  1  0
  4  6  2  0
 19 20  1  0
  9 10  2  0
 20 21  1  0
 10  5  1  0
 20 22  1  0
M  END

Alternative Forms

Associated Targets(Human)

ROCK2 Tclin Rho-associated protein kinase (137 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 297.45Molecular Weight (Monoisotopic): 297.2205AlogP: 4.16#Rotatable Bonds: 5
Polar Surface Area: 28.16Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.75CX LogP: 3.31CX LogD: 0.99
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.90Np Likeness Score: -1.30

References

1. Iwakubo M, Takami A, Okada Y, Kawata T, Tagami Y, Sato M, Sugiyama T, Fukushima K, Taya S, Amano M, Kaibuchi K, Iijima H..  (2007)  Design and synthesis of rho kinase inhibitors (III).,  15  (2): [PMID:17084087] [10.1016/j.bmc.2006.10.028]
2. Qin J, Lei B, Xi L, Liu H, Yao X..  (2010)  Molecular modeling studies of Rho kinase inhibitors using molecular docking and 3D-QSAR analysis.,  45  (7): [PMID:20347188] [10.1016/j.ejmech.2010.02.059]

Source